159 related articles for article (PubMed ID: 9679327)
1. Inhibition of RNA synthesis in vitro by acridines--relation between structure and activity.
Piestrzeniewicz MK; Wilmańska D; Studzian K; Szemraj J; Czyz M; Denny WA; Gniazdowski M
Z Naturforsch C J Biosci; 1998; 53(5-6):359-68. PubMed ID: 9679327
[TBL] [Abstract][Full Text] [Related]
2. Effect of DNA-interacting drugs on phage T7 RNA polymerase.
Piestrzeniewicz M; Studzian K; Wilmańska D; Płucienniczak G; Gniazdowski M
Acta Biochim Pol; 1998; 45(1):127-32. PubMed ID: 9701505
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanisms of inhibition of RNA synthesis. DNA-interacting inhibitors].
Gniazdowski M
Postepy Biochem; 1985; 31(1):53-86. PubMed ID: 2417218
[No Abstract] [Full Text] [Related]
4. The mechanism of inhibition of bacteriophage T7 RNA synthesis by acridines, diacridines and actinomycin D.
Sarris AH; Niles EG; Canellakis ES
Biochim Biophys Acta; 1977 Jan; 474(2):268-78. PubMed ID: 318865
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2.
Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
Biochemistry; 1999 Jul; 38(29):9221-33. PubMed ID: 10413496
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of site-specific topoisomerase II-mediated DNA cleavage by an N-methylpyrrolecarboxamide-anilinoacridine conjugate: relation to DNA binding.
Fossé P; René B; Saucier JM; Hénichart JP; Waring MJ; Colson P; Houssier C; Bailly C
Biochemistry; 1994 Aug; 33(33):9865-74. PubMed ID: 8060993
[TBL] [Abstract][Full Text] [Related]
7. A molecular modeling study of B-DNA-intercalation complexes with amsacrine and related 9-anilino-acridines.
Fischer G; Pindur U
Pharmazie; 1999 Feb; 54(2):83-93. PubMed ID: 10084153
[TBL] [Abstract][Full Text] [Related]
8. Influence of polyamine architecture on the transport and topoisomerase II inhibitory properties of polyamine DNA-intercalator conjugates.
Wang L; Price HL; Juusola J; Kline M; Phanstiel O
J Med Chem; 2001 Oct; 44(22):3682-91. PubMed ID: 11606133
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase II mediated DNA lesions induced by acridine-4-carboxamide and 2-(4-pyridyl)quinoline-8-carboxamide.
Woynarowski JM; McCarthy K; Reynolds B; Beerman TA; Denny WA
Anticancer Drug Des; 1994 Feb; 9(1):9-24. PubMed ID: 8141968
[TBL] [Abstract][Full Text] [Related]
10. Bisintercalating threading diacridines: relationships between DNA binding, cytotoxicity, and cell cycle arrest.
Wakelin LP; Bu X; Eleftheriou A; Parmar A; Hayek C; Stewart BW
J Med Chem; 2003 Dec; 46(26):5790-802. PubMed ID: 14667232
[TBL] [Abstract][Full Text] [Related]
11. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of DNA intercalating acridine-based drugs: how important are contributions from electron transfer and oxidative stress?
Baguley BC; Wakelin LP; Jacintho JD; Kovacic P
Curr Med Chem; 2003 Dec; 10(24):2643-9. PubMed ID: 14529454
[TBL] [Abstract][Full Text] [Related]
13. Kinetic studies of the binding of acridinecarboxamide topoisomerase poisons to DNA: implications for mode of binding of ligands with uncharged chromophores.
Wakelin LP; Adams A; Denny WA
J Med Chem; 2002 Feb; 45(4):894-901. PubMed ID: 11831901
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of ribonucleic acid polymerase by acridines.
Nicholson BH; Peacocke AR
Biochem J; 1966 Jul; 100(1):50-8. PubMed ID: 4290534
[TBL] [Abstract][Full Text] [Related]
15. Acridine derivatives as chemotherapeutic agents.
Denny WA
Curr Med Chem; 2002 Sep; 9(18):1655-65. PubMed ID: 12171548
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic and DNA-damaging properties of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and its analogues.
Pastwa E; Ciesielska E; Piestrzeniewicz MK; Denny WA; Gniazdowski M; Szmigiero L
Biochem Pharmacol; 1998 Aug; 56(3):351-9. PubMed ID: 9744573
[TBL] [Abstract][Full Text] [Related]
17. Potential antitumor agents. 45. Synthesis, DNA-binding interaction, and biological activity of triacridine derivatives.
Atwell GJ; Baguley BC; Wilmanska D; Denny WA
J Med Chem; 1986 Jan; 29(1):69-74. PubMed ID: 2416922
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
19. Effects of anticancer drugs on transcription in vitro.
Wilmańska D; Czyz M; Studzian K; Piestrzeniewicz MK; Gniazdowski M
Z Naturforsch C J Biosci; 2001; 56(9-10):886-91. PubMed ID: 11724400
[TBL] [Abstract][Full Text] [Related]
20. 9-substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationships.
Su TL; Chou TC; Kim JY; Huang JT; Ciszewska G; Ren WY; Otter GM; Sirotnak FM; Watanabe KA
J Med Chem; 1995 Aug; 38(17):3226-35. PubMed ID: 7650675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
